Tuesday, February 09, 2021 8:08:40 PM
1. A message from a private company NeuroRx triggers a drop in PPS, affecting its Partner Relief Therapeutics Inc., which trades on the stock exchange.
2. NeuroRx has no obligations to RLF, but tries to merge with BRPA, who are the only beneficiaries of this agreement and currently without any obligation.
3. For its part, RLFTF will connect to ACER through merger.
4. While NeuroRx has no further obligations too and has to wait for RLF-100 /(Avaptadil) to receive an EUA, their CEO, JJ, can make any statements to manipulate the market at his believe.
5. The credibility can be seen in the reaction of the small investors of RLF/RLFTF and BRPA.
6. Which performance is actually available can be seen out of the volatility (see above).
7. ....and, after price manipulation, investors are recruited again !
(see the link):
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM